OBJECTIVES: To evaluate the plasma leptin concentration in lean and genetically obese fa/fa rats and to assess the response to 2 h hyperinsulinaemia. BACKGROUND: The recently discovered peptide leptin is a putative link between the size of the adipose mass and the hypothalamic centres controlling feeding behaviour. Several genetic models of animal obesity have been characterized as carriers of mutations of either the ob gene or leptin receptor. EXPERIMENTAL DESIGN: Lean (/?) and obese (fa/fa) Zucker rats were studied under pentobarbital anaesthesia and underwent a 2 h euglycaemic hyperinsulinaemic clamp. Plasma leptin was measured in basal condition and at the end of the clamp study. Glucose rate of disappearance was evaluated by means of the isotope dilution technique using 3-3 H-glucose as tracer. RESULTS: fa/fa rats showed a 40 fold higher leptin concentration compared to lean littermates (0.47 AE 0.10 vs 19.55 AE 1.50 ng/ml, P`0.0001). Euglycaemic hyperinsulinaemia increased plasma leptin in lean but not in genetically obese rats. CONCLUSIONS: Our results suggest that insulin may be a regulator of in vivo leptin secretion by adipose tissue of lean rats whereas it is ineffective in increasing plasma leptin in obese Zucker rats.
Introduction
It has long been assumed that food intake and body weight stability are regulated by the hypothalamus. A negative feed-back from the periphery to the hypothalamic centres has been hypothesized and a crucial role has always been attributed to the size of the adipose mass. 1 The recently discovered peptide leptin is synthesized in and released from adipose tissue, and is indicated as the putative message from the adipose mass to the CNS. 2, 3 In fact, several studies reported that, both in humans and in animals, plasma leptin is positively correlated to body fat. 4, 5 Moreover ob/ob mice, which show a non-sense mutation in ob gene and lack circulating leptin are characterized by an abnormal body weight and adipose mass. Leptin administration to ob/ob mice leads to the reversal of overfeeding and reduction of body weight. 6 The regulation of ob gene expression in adipose tissue and of leptin plasma concentration is currently under major investigation. Several pieces of evidences have accumulated suggesting that insulin is a powerful inducer of ob gene expression in vivo in rats and in fat cell cultures. 7, 8 Data obtained in vitro and in vivo in rats indicated that insulin and feeding could rapidly regulate ob gene transcription, 7 but so far no data are available whether insulin can rapidly regulate circulating leptin in rats. Moreover, in humans longer stimulation by insulin is required to produce minor modi®cations of plasma leptin. 9 Therefore it is likely that the time-dependent regulation of ob gene expression is different in humans and rats. Genetically obese (fa/fa) Zucker rats have been characterized as having a mutation of the leptin receptor gene 10 and therefore the increased ob gene transcription may be secondary to leptin resistance. Little is known about the in vivo regulation of plasma leptin in rats, in particular whether insulin acutely regulates leptin and if this is deranged in a condition of insulin resistance such as the genetically obese fa/fa rat.
Therefore the aim of this investigation was to assess plasma leptin in response to acute (2 h) euglycaemic hyperinsulinaemia in fa/fa rats and their lean littermates.
Materials and methods
Animals and surgical procedure 10±12 week old male animals, 6 genetically obese Zucker ( fa/fa) rats and 10 lean (/?) littermates were used in this study. Mean weight was 274 AE 5 g for obese and 191 AE 6 g for lean rats. Animals were housed in our animal quarter with a 12 h light cycle and had free access to water and to a standard animal chow (Zoopharma, Padova, Italy). The protocol was approved by the Ethics Committee of the University of Padova and experiments were performed in agreement with the rules of laboratory animal care and the Italian law on animal experimentation. After an overnight fast, rats were anaesthetized by intraperitoneal injection of pentobarbital (50 mg/kg) and two indwelling catheters were inserted: one in the right jugular vein for infusion of glucose, insulin and tracer; the other in the left carotid artery for blood sampling, as previously described in detail. 11 Body temperature was maintained at 37 C throughout the study by means of a heating blanket connected to a rectal probe. No additional pentobarbital was administered after the clamp was started.
Euglycaemic hyperinsulinemic clamp
After 30 min of recovery following surgery, rats underwent a euglycaemic hyperinsulinaemic clamp under pentobarbital anaesthesia. An infusion of recombinant human insulin was started (15 mIU Á min 71 Á kg 71 in lean and 30 mIU Á min 71 Á kg 71 in obese rats) at time 0 min and baseline glucose concentration was maintained by means of a variable glucose infusion throughout the study (2 h). Plasma glucose was monitored at 5±10 min intervals in arterial samples (30 ml). Glucose turnover was calculated at steady state of the hyperinsulinaemic clamp by means of a primed-continuous infusion of 3-3 H-glucose (0.15 mCi Á min
71
) starting at time 0 min. Stable glucose speci®c activity was reached after 40 min of tracer infusion and arterial blood (50 ml) for measurement of tritiated glucose speci®c activity was collected at 10 min intervals during the last 60 min of the study. Glucose rate of disappearance (Rd) was calculated as previously described. 12 Arterial samples for insulin, leptin, lactate, FFA and glucose were collected at time 0 and after 2 h of the insulin clamp. Moreover plasma leptin and insulin concentrations were determined also at the end of the surgical procedure before the recovery period to assess the stability of insulin and leptin before the clamp study.
Analytical procedures
Plasma leptin was measured by a speci®c radioimmunoassay. In brief, recombinant human leptin (a gift from Dr Mark Heiman, Lilly Research Laboratories, Indianapolis, USA) was used for the production of antiserum in rabbit. Recombinant mouse leptin (Lilly Research Laboratories) was used for the preparation of tracer by conjugating the protein with 125 I by the Chloramine T method 13 and as standard. The assay buffer was composed of 0.05 mmol/l sodium phosphate, pH 7.4, 0.1 mmol/l NaCl, 0.05 (w:v) sodium azide, 0.1% (v:v) gelatine from teleost ®sh (Sigma) and 0.1% (v:v) Triton 100. The assay volume was 0.3 ml. After an overnight incubation at room temperature, bound and unbound tracer were separated by a second antibody against rabbit immunoglobulin. Maximal tracer binding was about 35±40% and half maximal binding occurred at 0.6 ng/ml unlabelled leptin. Spiking experiments with 0.1 ng leptin per tube yielded a recovery of 97%. Sensitivity was 0.01 ng/ml and the intra and interassay coef®cients of variations were 2.8% and 7.6% respectively. Cross reactivity between rat and mouse leptin was found to be 99.4 AE 0.8% over a wide range of leptin concentration (from 0.049±12.5 ng/ml).
Basal insulin was determined by a radioimmunoassay using an antibody raised against rat insulin and serial dilution of rat insulin as standard (Linco Res., St. Charles, MO, USA). End of clamp plasma insulin was measured using an immunoradiometric assay with 2 monoclonal antibodies against human insulin and dilution of human insulin as standards. Lactate and free fatty acids were measured using commercial kits with enzymatic-spectrophotometric techniques (Boehringer Mannheim, Germany). Glucose was assayed using the glucose oxidase method (Beckman glucose analyzer 2, CA, USA).
Results
Biochemical parameters of lean and genetically obese Zucker rats are summarized in Table 1 . Basal plasma glucose was comparable in lean and genetically obese rats and was maintained essentially constant (coef®-cient of variation 10%) throughout the study. Basal lactate was higher in obese rats compared to lean .001) and raised signi®cantly in lean animals at the end of clamp (1.02 AE 0.79 vs 1.47 AE 0.09 mmol/l, P`0.01) while being not further increased in fa/fa rats (3.62 AE 0.79 vs 3.10 AE 0.39 mmol/l). Despite the higher insulin levels reached at the end of the experiments, insulin-mediated overall glucose metabolism was signi®cantly lower in the obese animals (24.5 AE 0.5 vs 11.1 AE 0.62 mg Á min 71 Á kg 71 , P`0.001).
Arterial plasma leptin was not signi®cantly different immediately after surgery compared to after 30 min recovery both in lean (0.51 AE 0.20 vs 0.47 AE 0.10 ng/ml) and in obese rats (18.20 AE 0.50 vs 19.54 AE 1.50 ng/ml). Plasma leptin was markedly elevated in obese compared to lean rats (0.47 AE 0.10 vs 19.55 AE 1.50 ng/ml, P`0.0001). 2 h hyperinsulinaemia induced a 3.5-fold increase in leptin concentration in lean animals (0.47 AE 0.10 vs 1.64 AE 0.20 ng/ml, P`0.001) while in genetically obese rats plasma leptin was not further increased by hyperinsulinaemia (19.54 AE 1.50 vs 19.52 AE 1.21 ng/ml) ( Figure 1 ).
Discussion
This study was undertaken to investigate the role of insulin on in vivo regulation of plasma leptin concentration in Zucker lean and genetically obese fa/fa rats. The present data provide direct evidence for a role of insulin in regulating plasma leptin in lean animals. In fact a 3.5 fold increase of plasma leptin was observed at the end of a 2 h euglycaemic hyperinsulinaemic clamp. Moreover, obese rats displayed a markedly elevated basal leptin concentration (about 40 fold increased compared to lean controls), which were not further increased by insulin.
Data reported here are consistent with previous reports which showed an increased ob gene expression in adipose tissue from obese Zucker rats compared to lean littermates. 14 Moreover, Hardie and coworkers 15 reported that insulin administration increased leptin concentration in plasma. However the insulin clamp we used in our study offers the advantage of stable elevated circulating insulin without any change of blood glucose, which may be a counfounding factor. Also Maffei and coworkers 5 reported, using an immunoprecipitation assay, an increase in circulating leptin ( % 50 fold) in fa/fa rats which was quantitatively comparable to our results. An increased expression of ob gene is common to other non genetic models of animal obesity, such as the hypothalamically-lesioned rats and mice 16, 17 and diet induced obesity. 5 It was recently reported that fa/fa rats carry a mutation of the leptin receptor. 10 Therefore, a mechanism of receptor-mediated leptin resistance was proposed to explain the elevation of ob-gene expression in fa/fa rats and could therefore explain also the elevated circulating plasma leptin observed in fa/fa rats in our study. An alternative explanation to the increased basal leptin could be the 7 fold higher insulin concentration in the obese mutant compared to lean littermates. In fact it was reported that two days insulinisation' increases ob-gene expression in rats 8 and it is therefore possible that chronic hyperinsulinaemia may stimulate an increased leptin synthesis and secretion also in fa/fa rats. A support to this hypothesis is the observation that ob gene expression is not elevated in preweaning fa/fa rats, whereas its transcription increases in parallel with the rise of insulin after weaning and in adult animals. 8 The role of insulin in the regulation of ob gene expression and leptin concentration has been investigated by several authors 7±9 both in rats and humans. It was shown in rats that insulin administration increases ob gene mRNA after 6 h while 2 h exposure to insulin increases by 30% ob mRNA in cultured adipocytes 7 and stimulates dose-dependently leptin release from freshly isolated rat adipocytes. 18 On the contrary, prolonged insulin infusion (8 h) is required in humans in order to increase circulating leptin. 9 Data reported here show for the ®rst time that 2 h hyperinsulinaemia increases circulating leptin in lean rats, thus supporting the role of insulin in the short term regulation of plasma leptin in rats.
An inhibitory effect of insulin and glucose infusion on food intake was reported in animals. 19 The mechanism for this phenomenon is not completely understood, but it is possible that, apart from the direct effect of glucose and insulin on the CNS, the stimulation of leptin by hyperinsulinaemia may be a mechanism for induction of satiety after feeding. This mechanism may help in explaining the induction of satiety in rats but not in humans, in which the rise in plasma leptin occurs late at night and far from the meals.
Basal leptin was not further increased by hyperinsulinaemia in fa/fa rats, despite the higher plasma No variations in leptin concentration were observed in both groups before the beginning of the insulin clamp. At the end of the study a 3.5 fold increase was noted in lean rats whereas no increment was observed in fa/fa rats. Values represent mean AE SE. * P`0.001 compared to baseline value. Statistical analysis performed with ANOVA.
Insulin and plasma leptin in genetically obese rats C Pagano et al insulin concentrations reached in the obese animals. The mechanisms for the lack of effect of insulin in stimulating leptin in obese rats can be multiple. It is possible that ob gene expression is already maximally stimulated and cannot be further increased by supraphysiological insulin concentrations. An alternative possibility is that the ob gene is not under the control of insulin in such animals. Support for this view comes from the observation that fasting, though markedly reducing plasma insulin both in lean and obese Zucker rats, inhibits ob gene expression only in the former. 8 At present it is not clear whether hyperleptinaemia results only from the increased size of the adipose mass or if other hormonal, metabolic and neuroendocrine factors may also play a role. Our results and others 8 suggest that insulin, while being a regulator of leptin in lean rats, is ineffective in fa/fa rats. It is not clear if insulin resistance may in¯uence leptin secretion by adipose tissue. Regression analysis studies carried out in humans do not support a role for insulin resistance in in¯uencing leptin concentrations 20 and it has been reported that the most relevant determinant of circulating leptin is the size of the adipose mass. 4 Moreover it is well known that in the early phase of obesity development in fa/fa rats, insulin resistance is mainly localized in liver and skeletal muscle whereas insulin sensitivity is preserved in adipose tissue. 21 It is possible to believe that this pattern of insulin sensitivity was present also in our young fa/fa rats. Although higher insulin concentrations were reached in our fa/fa compared to lean rats (due to the different blood circulating volume compared to body mass in obese animals), a blunted glucose disposal was observed, thus con®rming a condition of profound insulin resistance in fa/fa rats. Despite this, no correlation was found between glucose Rd and plasma leptin in obese animals (data not shown) thus supporting the lack of impact of insulin resistance in the regulation of leptin concentration.
Conclusions
Our data support a role for insulin in acute regulation of circulating leptin concentration in normal rats. These results further indicate that insulin and leptin may be involved in the regulation of satiety and may participate in short-term regulation of feeding behaviour in rats. On the contrary obese fa/fa rats have much higher basal leptin, but failed to respond to sustained hyperinsulinaemia during clamp. Thus it is possible to speculate that the lack of response of ob gene product to insulin may depend on its maximal stimulation due to the elevated insulin concentrations in obese fa/fa rats.
